Emel Akan is a senior White House correspondent for The Epoch Times, where she covers the policies of the Trump administration. Previously, she reported on the Biden administration and the first term of President Trump. Before her journalism career, she worked in investment banking at JPMorgan. She holds an MBA from Georgetown University.
China’s iron grip on supply of critical drug ingredients has been years in the making, driven by Beijing’s strategic plan to dominate the pharma industry